News

A team from Stanford University has developed the world's first amphibious all-terrain vehicle for medicine delivery. The millimeter-scale robot was created to negotiate complex biological environments by rolling, flipping, and spinning adverse effects through liquids. The fabrication of wirelessly controlled...

As per University of Manchester studies funded by the British Heart Foundation (BHF) and published in Proceedings of the National Academy of Sciences, a significant development in the understanding of Alzheimer's disease has put forth changes to blood vessels in the brain,...

The University of Sydney has revealed that the New South Wales (NSW) state will contribute $143.3 million over four years to the construction of a world-class health and technology centre in Sydney. The Sydney Biomedical Accelerator (SBA) will be...

Third Rock Ventures, a well-known funder of biotech startups, announced the closure of a billion-dollar fund recently that would be used to create and grow new life sciences businesses. The fund, Third Rock's sixth, is introduced in the midst of a...

Pfizer, the world's largest pharmaceutical company, has decided to invest 90.5 million euros ($95.24 million) in Valneva, a French vaccine company, as the businesses reported further advancements in their Lyme disease collaboration. Pfizer will purchase a 9.49 euro per share...

Pharmacists do so much more than just refill prescriptions. They offer general advice to customers, discuss medication usage with customers, and will occasionally offer vaccines. As such, coming up with solutions for how to reduce the workload for pharmacists...

Doctors currently use a variety of tests to identify Alzheimer's disease, including memory and cognitive tests that can take several weeks to set up and interpret. Only one of these is required in the new method, which is an...